<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Idiopathic acute eosinophilic pneumonia</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Idiopathic acute eosinophilic pneumonia</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Idiopathic acute eosinophilic pneumonia</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Talmadge E King, Jr, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kevin R Flaherty, MD, MS</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paul Dieffenbach, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Aug 01, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Idiopathic acute eosinophilic pneumonia (AEP) was first described as a cause of acute respiratory failure in 1989 [<a href="#rid1">1,2</a>]. Subsequently, cases of AEP have been reported worldwide [<a href="#rid3">3-6</a>]. Although both AEP and chronic eosinophilic pneumonia (CEP) are characterized by eosinophilic infiltration of the pulmonary parenchyma, these disorders are clinically distinct [<a href="#rid7">7</a>].</p><p>The clinical features and management of idiopathic acute eosinophilic pneumonia will be reviewed here. Other conditions associated with pulmonary eosinophilia are presented separately  (<a class="graphic graphic_table graphicRef65178" href="/z/d/graphic/65178.html" rel="external">table 1</a>).</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/5715.html" rel="external">"Overview of pulmonary eosinophilia"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/4360.html" rel="external">"Chronic eosinophilic pneumonia"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/6704.html" rel="external">"Pleural fluid eosinophilia"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/4363.html" rel="external">"Epidemiology, pathogenesis, and pathology of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/4347.html" rel="external">"Clinical features and diagnosis of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/4346.html" rel="external">"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): Treatment and prognosis"</a>.)</p><p></p><p>Other etiologies of acute diffuse parenchymal lung infiltrates are likewise discussed elsewhere:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/1609.html" rel="external">"Acute respiratory distress syndrome: Epidemiology, pathophysiology, pathology, and etiology in adults"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/1637.html" rel="external">"Acute respiratory distress syndrome: Clinical features, diagnosis, and complications in adults"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/4369.html" rel="external">"Acute interstitial pneumonia (Hamman-Rich syndrome)"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/4341.html" rel="external">"The diffuse alveolar hemorrhage syndromes"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/4332.html" rel="external">"Cryptogenic organizing pneumonia"</a>.)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">ETIOLOGY</span><span class="headingEndMark"> — </span>The cause of acute eosinophilic pneumonia (AEP) remains unknown. Some investigators have suggested that AEP is an acute hypersensitivity reaction to an unidentified inhaled antigen in an otherwise healthy individual [<a href="#rid1">1</a>]. The following observations are consistent with this hypothesis:</p><p class="bulletIndent1"><span class="glyph">●</span>In several reports, patients have been involved in unusual outdoor activities just prior to the onset of their illness [<a href="#rid1">1,8-10</a>]. As an example, AEP developed in at least one firefighter following the collapse of the World Trade Center towers in 2001 [<a href="#rid10">10</a>]. Another case developed in a young male smoker after he inhaled smoke from fireworks for three consecutive nights [<a href="#rid11">11</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A temporal relationship has been described in a number of patients between the development of AEP and the recent onset of cigarette smoking (for the first time or following a period of smoking cessation) [<a href="#rid8">8,12-24</a>]. In one patient, a cigarette-smoking challenge test led to recurrence of eosinophilic pneumonia [<a href="#rid13">13</a>]. In contrast, the process resolved in another patient despite continued cigarette smoking [<a href="#rid25">25</a>]. An association between passive smoking and AEP has also been reported [<a href="#rid26">26</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>AEP has been described in water pipe users who smoke tobacco or marijuana [<a href="#rid27">27,28</a>]. Water pipe smoking increases the volume of smoke inhaled and the concentration of ultrafine particles, compared with cigarettes. Electronic cigarettes and "heat-not-burn" devices have been associated with AEP in separate reports [<a href="#rid29">29-36</a>]. AEP has also been associated with aromatherapy following fragrance oil inhalation [<a href="#rid37">37,38</a>]. (See  <a class="medical medical_review" href="/z/d/html/6916.html" rel="external">"Patterns of tobacco use", section on 'Other forms of tobacco'</a> and  <a class="medical medical_review" href="/z/d/html/98400.html" rel="external">"Vaping and e-cigarettes"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Eighteen cases of AEP were described among over 180,000 military personnel deployed in or near Iraq from March 2003 to March 2004 and treated at Landstuhl Regional Medical Center (LRMC) [<a href="#rid15">15</a>]. All patients smoked, and the onset of smoking was recent in 14. All but one patient had significant exposure to fine airborne sand or dust; no other common source exposure could be identified. A retrospective chart review of 43 total cases of AEP in military personnel treated at LRMC from 2003 to 2010 found that 91 percent were cigarette smokers and 77 percent had recently started or increased their smoking [<a href="#rid39">39</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The possible role of environmental factors in the home was addressed in a study in which provocation challenges were performed in the homes of stable patients with a recent history of AEP [<a href="#rid40">40</a>]. The challenge resulted in the development of a similar illness with fever, cough, fatigue, and dyspnea. Inspiratory crackles became audible and hypoxemia developed in all cases. Similar challenges at the patients' workplaces were negative. After moving out of their homes, the patients engaged in their usual work and experienced no recurrent episodes.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Isolated cases of AEP have been described in HIV-infected patients, and following inhalation of cocaine or heroin [<a href="#rid41">41-43</a>]. The pathogenesis of these possible associations is not known.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Several cases of AEP presumably triggered by SARS-CoV-2 infection have been described [<a href="#rid44">44-46</a>]. </p><p></p><p class="headingAnchor" id="H1153433304"><span class="h1">PATHOLOGY</span><span class="headingEndMark"> — </span>Few patients with acute eosinophilic pneumonia (AEP) have undergone lung biopsy other than by transbronchial biopsy [<a href="#rid47">47,48</a>]. One series described nine open and thoracoscopic lung biopsies from the consultation and teaching files of the Mayo Clinic [<a href="#rid47">47,48</a>]. Key histopathologic features included:</p><p class="bulletIndent1"><span class="glyph">●</span>Severe extent of disease, with abnormalities in over 75 percent of the surface area of the lung sampled.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Acute and organizing diffuse alveolar damage (DAD) was common. Hyaline membranes and interstitial widening (due to a combination of edema, fibroblast proliferation, and inflammatory cells characteristic of the organizing phase of DAD) were each seen in 78 percent of cases. (See  <a class="medical medical_review" href="/z/d/html/4369.html" rel="external">"Acute interstitial pneumonia (Hamman-Rich syndrome)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Marked numbers of interstitial and lesser numbers of alveolar eosinophils were found in all samples  (<a class="graphic graphic_picture graphicRef74556" href="/z/d/graphic/74556.html" rel="external">picture 1</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other features included: type II pneumocyte hyperplasia (55 percent of cases), interstitial lymphocytes (100 percent of cases), an organizing intraalveolar fibrinous exudate (100 percent of cases), and perivascular and intramural inflammation without necrosis (33 percent of cases)  (<a class="graphic graphic_picture graphicRef58648" href="/z/d/graphic/58648.html" rel="external">picture 2</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Granulomas and alveolar hemorrhage were absent.</p><p></p><p class="headingAnchor" id="H3"><span class="h1">CLINICAL FEATURES</span><span class="headingEndMark"> — </span>Acute eosinophilic pneumonia (AEP) is a rare disease, and the clinical studies that are available have been retrospective in nature [<a href="#rid8">8,18,24,49</a>]. AEP can occur at any age, even in previously healthy children, though most patients are between 20 and 40 years of age [<a href="#rid50">50,51</a>]. Men are affected approximately twice as frequently as women [<a href="#rid1">1,2,9,52-55</a>]. A minority have a history of allergic disease [<a href="#rid19">19</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical presentation</strong> – Patients present with an acute illness of less than four weeks duration; in most cases the duration of symptoms is less than seven days. Nonproductive cough (95 percent), dyspnea (92 percent), and fever (88 percent) are present in almost every patient [<a href="#rid19">19</a>]. Associated symptoms and signs can include malaise, myalgias, night sweats, chills, and pleuritic chest pain [<a href="#rid19">19</a>].</p><p></p><p class="bulletIndent1">Physical examination shows fever (often high) and tachypnea. Bibasilar inspiratory crackles and occasionally rhonchi on forced exhalation are heard upon auscultation of the chest [<a href="#rid19">19,55,56</a>]. Clubbing and signs of cor pulmonale have not been reported.</p><p></p><p class="bulletIndent1">Hypoxemic respiratory insufficiency is frequently identified at presentation and often requires mechanical ventilation. In one series, 14 of 22 patients (63 percent) developed respiratory failure and required mechanical ventilation [<a href="#rid8">8</a>]. Hyperdynamic shock has been reported, but is unusual [<a href="#rid57">57</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Laboratory features</strong> – Patients generally present with an initial neutrophilic leukocytosis [<a href="#rid8">8,12,19</a>]. In most cases, the eosinophil fraction is not elevated initially, but may become markedly elevated during the subsequent course [<a href="#rid8">8,54,56,58</a>]. The erythrocyte sedimentation rate and C-reactive protein are elevated, and the IgE level has been high in a majority of the patients in whom it was measured [<a href="#rid40">40,52-55</a>].</p><p></p><p class="headingAnchor" id="H1153431652"><span class="h1">EVALUATION</span><span class="headingEndMark"> — </span>Acute eosinophilic pneumonia (AEP) is typically suspected in a patient with progressive dyspnea less than a month in duration and a chest radiograph showing diffuse parenchymal opacities. Among the first steps in the evaluation is to ask the patient about medication usage, particularly any drugs associated with pulmonary eosinophilia (eg, cocaine, <a class="drug drug_general" data-topicid="9304" href="/z/d/drug information/9304.html" rel="external">daptomycin</a>, <a class="drug drug_general" data-topicid="8487" href="/z/d/drug information/8487.html" rel="external">gemcitabine</a>, <a class="drug drug_general" data-topicid="8984" href="/z/d/drug information/8984.html" rel="external">infliximab</a>, <a class="drug drug_general" data-topicid="9853" href="/z/d/drug information/9853.html" rel="external">ranitidine</a>, <a class="drug drug_general" data-topicid="9963" href="/z/d/drug information/9963.html" rel="external">sulfasalazine</a>/<a class="drug drug_general" data-topicid="9614" href="/z/d/drug information/9614.html" rel="external">mesalamine</a>, <a class="drug drug_general" data-topicid="10042" href="/z/d/drug information/10042.html" rel="external">venlafaxine</a>), previous irradiation of the chest, or travel or residence in an area with an increased likelihood of exposure to endemic parasites or fungi  (<a class="graphic graphic_table graphicRef65178" href="/z/d/graphic/65178.html" rel="external">table 1</a>) [<a href="#rid59">59-69</a>].</p><p class="headingAnchor" id="H5"><span class="h2">Laboratory studies</span><span class="headingEndMark"> — </span>No laboratory studies are specific for AEP. However, in the evaluation of patients with dyspnea, cough, fever, and radiographic pulmonary opacities, the usual laboratory tests include a complete blood count and differential, blood urea nitrogen, creatinine, hepatic function tests, urinalysis, and blood cultures. As noted above, patients do not typically have peripheral blood eosinophilia at the time of presentation [<a href="#rid2">2,70</a>]. </p><p>Certain laboratory tests are helpful to evaluate for diseases in the differential diagnosis of AEP:</p><p class="bulletIndent1"><span class="glyph">●</span>An antineutrophil cytoplasmic antibody (ANCA) test for granulomatosis with polyangiitis (GPA) or eosinophilic granulomatosis with polyangiitis (EGPA, Churg Strauss). However, ANCA is only positive in 40 to 60 percent of patients with EGPA, so a negative test doesn’t exclude the diagnosis. (See  <a class="medical medical_review" href="/z/d/html/4330.html" rel="external">"Granulomatosis with polyangiitis and microscopic polyangiitis: Respiratory tract involvement", section on 'Laboratory tests'</a> and  <a class="medical medical_review" href="/z/d/html/4347.html" rel="external">"Clinical features and diagnosis of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)", section on 'Antineutrophil cytoplasmic antibodies'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Enzyme-linked immunoassays for IgM and IgG specific for <em>Coccidioides</em>. (See  <a class="medical medical_review" href="/z/d/html/2420.html" rel="external">"Coccidioidomycosis: Laboratory diagnosis and screening"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Enzyme-linked immunosorbent assay (ELISA) or other serologic test for <em>Strongyloides</em> or <em>Paragonimiasis</em>, depending on likelihood of exposure. (See  <a class="medical medical_review" href="/z/d/html/5714.html" rel="external">"Strongyloidiasis", section on 'Serology'</a>.)  </p><p></p><p>In a small series, the expectorated sputum showed eosinophilia in six of nine patients, but the sensitivity and specificity of sputum cell counts have not been formally evaluated [<a href="#rid54">54</a>]. </p><p>If an adequate amount of pleural fluid is present, thoracentesis is generally indicated. Pleural fluid may demonstrate a marked eosinophilia (10 to 50 percent) [<a href="#rid6">6-9,20,55,71</a>].</p><p class="headingAnchor" id="H6"><span class="h2">Imaging</span><span class="headingEndMark"> — </span>At the onset of AEP, the chest radiograph may show only subtle reticular or ground glass opacities, often with Kerley B lines [<a href="#rid71">71,72</a>]. As the disease progresses, bilateral diffuse mixed ground glass and reticular opacities develop [<a href="#rid1">1,2,9,52-55,72</a>]  (<a class="graphic graphic_diagnosticimage graphicRef50572 graphicRef71567" href="/z/d/graphic/50572.html" rel="external">image 1A-B</a>). Isolated ground glass (approximately 25 percent of cases) or reticular (approximately 25 percent of cases) opacities may also be seen on presentation. The distribution of opacities in AEP is diffuse, unlike chronic eosinophilic pneumonia, in which the opacities are typically localized to the lung periphery. (See  <a class="medical medical_review" href="/z/d/html/6979.html" rel="external">"Evaluation of diffuse lung disease by conventional chest radiography"</a>.)</p><p>Small pleural effusions are common (noted in up to 70 percent of patients) and are frequently bilateral [<a href="#rid8">8,58,61</a>]. </p><p>High-resolution computed tomography (HRCT) scans are not essential to the diagnosis but can help characterize the distribution of opacities and guide selection of an area of involvement for bronchoalveolar lavage. The HRCT is always abnormal in patients with AEP and is characterized by bilateral, random, and patchy ground-glass or reticular opacities  (<a class="graphic graphic_diagnosticimage graphicRef101077" href="/z/d/graphic/101077.html" rel="external">image 2</a>) [<a href="#rid19">19,73</a>]. Centrilobular nodules and air-space consolidation are seen in approximately 50 and 40 percent, respectively [<a href="#rid19">19</a>]. In mild cases, the lesions are sparse or localized [<a href="#rid54">54,74</a>]. At the height of the disease process, HRCT reveals ground-glass opacities along the bronchovascular bundles. Pleural effusions, usually bilateral, are present in almost 90 percent. (See  <a class="medical medical_review" href="/z/d/html/6988.html" rel="external">"High resolution computed tomography of the lungs"</a>.)</p><p class="headingAnchor" id="H8"><span class="h2">Pulmonary function tests</span><span class="headingEndMark"> — </span>Due to the acute presentation, it is often not possible to obtain pulmonary function tests. When performed, a restrictive process may be noted (reduced forced vital capacity [FVC] and total lung capacity with a normal forced expiratory volume in one second [FEV<sub>1</sub>]/FVC); diffusing capacity for carbon monoxide (DLCO) is commonly reduced [<a href="#rid7">7,9,55</a>]. </p><p>Oxygenation is typically monitored by pulse oximetry.</p><p class="headingAnchor" id="H11"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>The diagnosis of acute eosinophilic pneumonia (AEP) is typically based upon clinical criteria that include bronchoalveolar lavage (BAL) eosinophilia with exclusion of known causes of pulmonary eosinophilia  (<a class="graphic graphic_table graphicRef65178" href="/z/d/graphic/65178.html" rel="external">table 1</a>). Lung biopsy is rarely necessary.</p><p class="headingAnchor" id="H89098322"><span class="h2">Diagnostic criteria</span><span class="headingEndMark"> — </span>A confident diagnosis of AEP can usually be made without a lung biopsy in patients who meet the following criteria [<a href="#rid7">7,8,71,75</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>A febrile illness of short duration (one month or less, but often less than one week)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hypoxemic respiratory failure (eg, pulse oxygen saturation [SpO<sub>2</sub>] &lt;90 percent on room air or arterial oxygen tension [PaO<sub>2</sub>] &lt;60 mmHg)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Diffuse pulmonary opacities on chest radiograph</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>BAL differential cell count showing eosinophilia &gt;25 percent</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Absence of known causes of eosinophilic pneumonia, including drugs, infections, asthma, or atopic disease  (<a class="graphic graphic_table graphicRef65178" href="/z/d/graphic/65178.html" rel="external">table 1</a>) (see  <a class="medical medical_review" href="/z/d/html/5715.html" rel="external">"Overview of pulmonary eosinophilia"</a>)</p><p></p><p class="headingAnchor" id="H1322856955"><span class="h2">Bronchoscopy with bronchoalveolar lavage</span><span class="headingEndMark"> — </span>BAL is performed in the majority of patients to quantitate eosinophilia and to exclude infection, hemorrhage, or malignancy (eg, germ cell tumor, leukemia). The BAL is performed using a sequential instillation and recovery of 50 to 60 mL aliquots (to evaluate for hemorrhage) in an area of radiographic opacity. Samples are sent for cell count, microbiologic studies, and cytology. (See  <a class="medical medical_review" href="/z/d/html/4308.html" rel="external">"Role of bronchoalveolar lavage in diagnosis of interstitial lung disease"</a> and  <a class="medical medical_review" href="/z/d/html/4379.html" rel="external">"Role of lung biopsy in the diagnosis of interstitial lung disease"</a>.)</p><p>In AEP, the BAL fluid typically shows a very high proportion (&gt;25 percent) and total number of eosinophils [<a href="#rid8">8,9,39,49,54,55</a>]. While data on other cell counts are limited, the proportion of BAL lymphocytes is approximately 10 to 30 percent and the proportion of BAL neutrophils is 1 to 16 percent [<a href="#rid9">9,14,19,26</a>]. The level of eosinophilia returns to normal when the illness resolves [<a href="#rid9">9,54,55</a>]. </p><p class="headingAnchor" id="H1322857195"><span class="h2">Lung biopsy</span><span class="headingEndMark"> — </span>Lung biopsy is rarely necessary to make a diagnosis of AEP in immunocompetent patients with a compatible history and prominent BAL eosinophilia in the absence of infection or another known precipitant [<a href="#rid7">7,8,75</a>]. Indications for lung biopsy would include concern about an infectious etiology that could not be quickly excluded by BAL or failure to respond to systemic glucocorticoids. </p><p class="headingAnchor" id="H1153431536"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>For patients with acute, fulminant respiratory failure, diffuse radiographic opacities, and bronchoalveolar lavage (BAL) eosinophilia, the differential diagnosis includes:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Eosinophilic granulomatosis with polyangiitis</strong> – Eosinophilic granulomatosis with polyangiitis (EGPA, Churg Strauss), like acute eosinophilic pneumonia (AEP), can present with progressive respiratory insufficiency, fever, radiographic pulmonary opacities, and BAL eosinophilia. However, peripheral blood eosinophilia &gt;10 percent is characteristic of EGPA and uncommon at presentation in AEP. In addition, the multisystemic involvement typically seen in EGPA would be absent in AEP. (See  <a class="medical medical_review" href="/z/d/html/4347.html" rel="external">"Clinical features and diagnosis of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)", section on 'Diagnostic criteria'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fungal infection</strong> – Infections due to <em>Coccidioides immitis</em> and <em>Trichosporon</em> species can cause acute eosinophilic pneumonia [<a href="#rid76">76-79</a>]. For <em>Coccidioides</em>, a history of travel or residence in an endemic area should alert the clinician to the possibility. The cases of acute eosinophilic pneumonia associated with Trichosporon have all been reported from Japan, and there may be a degree of overlap with summer-type hypersensitivity pneumonitis [<a href="#rid79">79</a>]. In one case report, AEP was caused by the inhalation of a large amount of vapor released by a household composter [<a href="#rid80">80</a>]. Aspergillus fumigatus was cultured from the composter soil and the bronchoalveolar lavage fluid. (See  <a class="medical medical_review" href="/z/d/html/5715.html" rel="external">"Overview of pulmonary eosinophilia", section on 'Fungal and mycobacterial infections'</a> and  <a class="medical medical_review" href="/z/d/html/2460.html" rel="external">"Primary pulmonary coccidioidal infection", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent1">In another case report, invasive aspergillosis mimicked AEP in a patient with previously undiagnosed chronic granulomatous disease (caused by defects in phagocyte nicotinamide adenine dinucleotide phosphate [NADPH] oxidase) [<a href="#rid81">81</a>]. (See  <a class="medical medical_review" href="/z/d/html/3925.html" rel="external">"Chronic granulomatous disease: Pathogenesis, clinical manifestations, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Parasitic infection</strong> – Infections due to <em>Ascaris</em>, <em>Paragonimus</em>, <em>Strongyloides</em>, and <em>Toxocara</em> can present with diffuse pulmonary opacities and peripheral blood and BAL eosinophilia. Often, a history of travel or residence in an endemic area will alert the clinician to the possibility. (See  <a class="medical medical_review" href="/z/d/html/5715.html" rel="external">"Overview of pulmonary eosinophilia", section on 'Helminth infections'</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Eosinophilic pneumonia due to drugs, toxins, and lung irradiation</strong> – Eosinophilic pneumonia can be caused by drugs, toxins, and lung irradiation; these possibilities are best investigated by a careful history  (<a class="graphic graphic_table graphicRef65178" href="/z/d/graphic/65178.html" rel="external">table 1</a>) [<a href="#rid26">26</a>]. (See  <a class="medical medical_review" href="/z/d/html/5715.html" rel="external">"Overview of pulmonary eosinophilia", section on 'Medications and toxins'</a>.)</p><p></p><p>Other processes that might have a similar clinical presentation, but without BAL eosinophilia include acute respiratory distress syndrome (ARDS), acute interstitial pneumonia, fulminant cryptogenic organizing pneumonia (COP), diffuse alveolar hemorrhage (DAH), and granulomatosis with polyangiitis (GPA). (See  <a class="medical medical_review" href="/z/d/html/1637.html" rel="external">"Acute respiratory distress syndrome: Clinical features, diagnosis, and complications in adults", section on 'Diagnosis'</a> and  <a class="medical medical_review" href="/z/d/html/4369.html" rel="external">"Acute interstitial pneumonia (Hamman-Rich syndrome)", section on 'Diagnosis'</a> and  <a class="medical medical_review" href="/z/d/html/4341.html" rel="external">"The diffuse alveolar hemorrhage syndromes"</a> and  <a class="medical medical_review" href="/z/d/html/4330.html" rel="external">"Granulomatosis with polyangiitis and microscopic polyangiitis: Respiratory tract involvement", section on 'Bronchoscopy'</a> and  <a class="medical medical_review" href="/z/d/html/4332.html" rel="external">"Cryptogenic organizing pneumonia", section on 'Diagnosis'</a>.)</p><p class="headingAnchor" id="H12"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span>Initial management of acute eosinophilic pneumonia (AEP) usually includes supportive care with supplemental oxygen and possibly mechanical ventilation, empiric antibiotics until culture results are available, and systemic glucocorticoid therapy. While clinical trial data are lacking, most patients with AEP experience progressive respiratory failure without systemic glucocorticoid therapy, but improve rapidly (within 12 to 48 hours) in response to intravenous or oral glucocorticoid therapy [<a href="#rid8">8,19,54-56</a>]. Occasional patients with milder initial disease have experienced spontaneous improvement following smoking cessation and without glucocorticoid therapy [<a href="#rid8">8,19,24,54,55</a>]. Thus, we recommend treatment with systemic glucocorticoids for almost all patients with AEP (after exclusion of infectious causes), except those with clear evidence of an improving course [<a href="#rid82">82</a>]. </p><p>The optimal dose or length of glucocorticoid treatment is not known, and initial therapy often varies based upon the severity of disease:</p><p class="bulletIndent1"><span class="glyph">●</span>In the presence of severe hypoxemia or respiratory failure requiring mechanical ventilation, <a class="drug drug_general" data-topicid="9639" href="/z/d/drug information/9639.html" rel="external">methylprednisolone</a> (60 to 125 mg every six hours) is given until respiratory failure resolves (usually within one to three days).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In the absence of respiratory failure (eg, pulse oxygen saturation &gt;92 percent on low-flow supplemental oxygen), initial treatment with oral <a class="drug drug_general" data-topicid="9809" href="/z/d/drug information/9809.html" rel="external">prednisone</a> (40 to 60 mg daily) is reasonable.</p><p></p><p>Oral <a class="drug drug_general" data-topicid="9809" href="/z/d/drug information/9809.html" rel="external">prednisone</a> in a dose of 40 to 60 mg per day is then continued for two weeks beyond the complete resolution of symptoms and abnormalities on the chest radiograph [<a href="#rid19">19,71</a>]. At that time, the dose can be reduced by 5 mg every seven days until complete cessation of therapy [<a href="#rid2">2,9,19,82</a>]. If the patient shows clinical stabilization with rapid resolution of all symptoms, then earlier glucocorticoid tapering (over 7 to 14 days) may be an acceptable treatment strategy especially for AEP patients who present with initial eosinophilia [<a href="#rid83">83</a>]. </p><p>A longer treatment course (up to four weeks) with tapering and discontinuing of <a class="drug drug_general" data-topicid="9809" href="/z/d/drug information/9809.html" rel="external">prednisone</a> over the subsequent two to four weeks may occasionally be required in patients who experienced severe respiratory failure with delayed resolution of symptoms and radiographic abnormalities.</p><p>If a patient fails to respond to glucocorticoids, an alternative diagnosis should be entertained. There are no data on treatments other than glucocorticoids.</p><p class="headingAnchor" id="H1153433696"><span class="h1">OUTCOMES</span><span class="headingEndMark"> — </span>Symptomatic and radiographic improvement is usually rapid and progressive with complete radiographic clearing over one to two months after initiation of systemic glucocorticoids [<a href="#rid8">8</a>]. Similarly, pulmonary function tests return to normal after recovery from the illness [<a href="#rid8">8</a>].</p><p>Relapse is uncommon and is usually associated with resumption of cigarette smoking after initial cessation [<a href="#rid14">14,18-20,24</a>].</p><p>The pleural effusions may resolve more slowly than the pulmonary parenchymal opacities [<a href="#rid9">9</a>]. </p><p class="headingAnchor" id="H3583230604"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/118793.html" rel="external">"Society guideline links: Interstitial lung disease"</a>.)</p><p class="headingAnchor" id="H13"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Presentation</strong> – Idiopathic acute eosinophilic pneumonia (AEP) typically presents with an acute febrile illness of less than four weeks duration (often less than seven days), a nonproductive cough, and progressively worsening dyspnea. Associated symptoms and signs may include malaise, myalgias, night sweats, and pleuritic chest pain. (See <a class="local">'Introduction'</a> above and <a class="local">'Clinical features'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Etiology</strong> – AEP has been associated most often with new onset or resumption of cigarette smoking. Heavy inhalational exposure to smoke, fine sand, and dust has also been associated with AEP. (See <a class="local">'Etiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathology</strong> – Lung histopathology obtained in a small number of patients reveals extensive abnormality with marked eosinophilic infiltration in the interstitium and alveolar spaces, acute and/or organizing diffuse alveolar damage, and absence of granulomas or hemorrhage. (See <a class="local">'Pathology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Laboratory studies</strong> – At presentation, the peripheral blood count usually shows a neutrophilic leukocytosis without eosinophilia, although peripheral blood eosinophilia may develop over the course of the disease. (See <a class="local">'Laboratory studies'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Imaging</strong> – The initial chest radiograph may show only subtle reticular or ground glass opacities, often with Kerley B lines. As the disease progresses, bilateral diffuse mixed ground glass and reticular opacities develop. Typical findings on high-resolution computed tomography (HRCT) scans include bilateral, random, and patchy ground-glass or reticular opacities and also small bilateral pleural effusions. (See <a class="local">'Imaging'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – A confident diagnosis of AEP can usually be made on the basis of the combination of an acute febrile illness of short duration (one month or less), hypoxemic respiratory failure, diffuse pulmonary opacities on chest radiograph, and bronchoalveolar lavage eosinophilia (&gt;25 percent), after exclusion of infection, vasculitis, or other known precipitants (eg, drugs, irradiation)  (<a class="graphic graphic_table graphicRef65178" href="/z/d/graphic/65178.html" rel="external">table 1</a>). (See <a class="local">'Diagnosis'</a> above and  <a class="medical medical_review" href="/z/d/html/5715.html" rel="external">"Overview of pulmonary eosinophilia"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Initial treatment</strong> – For the majority of patients with AEP, we recommend treatment with systemic glucocorticoids after exclusion of infection (<a class="grade" href="https:///uptodate/show/grade_2" rel="external">Grade 1B</a>). This recommendation is due to the severity and progressive nature of respiratory impairment and the dramatic response to glucocorticoids. The optimal dose of glucocorticoids is not known, but a reasonable course is to select the dose based upon the severity of respiratory impairment. (See <a class="local">'Treatment'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In the presence of severe hypoxemia or respiratory failure requiring mechanical ventilation, <a class="drug drug_general" data-topicid="9639" href="/z/d/drug information/9639.html" rel="external">methylprednisolone</a> (60 to 125 mg every six hours) is given until respiratory failure resolves (usually within one to three days).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In the absence of respiratory failure (eg, pulse oxygen saturation &gt;92 percent on room air), initial treatment with oral <a class="drug drug_general" data-topicid="9809" href="/z/d/drug information/9809.html" rel="external">prednisone</a> (40 to 60 mg daily) is reasonable.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Tapering therapy</strong> – Oral <a class="drug drug_general" data-topicid="9809" href="/z/d/drug information/9809.html" rel="external">prednisone</a> is continued at a dose of 40 to 60 mg per day for two weeks beyond the complete resolution of symptoms and conventional chest radiograph abnormalities. Prednisone is then tapered over approximately four weeks and discontinued. (See <a class="local">'Treatment'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Exposure avoidance</strong> – As cigarette smoking initiation or increase in amount are often associated with AEP and as relapses have been associated with resumption of smoking, complete smoking cessation should be strongly encouraged. Relapses have not been well-documented in other cases of acute exposures, but avoidance is prudent when an etiology can be identified. (See <a class="local">'Treatment'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prognosis</strong> – Symptomatic and radiographic improvement is usually rapid and progressive with complete radiographic clearing over one to two months. Relapse is uncommon and is usually attributable to resumption of cigarette smoking after initial cessation. (See <a class="local">'Outcomes'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Badesch DB, King TE Jr, Schwarz MI. Acute eosinophilic pneumonia: a hypersensitivity phenomenon? Am Rev Respir Dis 1989; 139:249.</a></li><li><a class="nounderline abstract_t">Allen JN, Pacht ER, Gadek JE, Davis WB. Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure. N Engl J Med 1989; 321:569.</a></li><li><a class="nounderline abstract_t">Arrese M, Castellón JM, Contreras G. [Eosinophilic pneumonia causing severe respiratory insufficiency. Clinical case]. Rev Med Chil 1991; 119:299.</a></li><li><a class="nounderline abstract_t">Nishio M, Ohata M, Suruda T, et al. Idiopathic acute eosinophilic pneumonia. Intern Med 1992; 31:1139.</a></li><li><a class="nounderline abstract_t">Slabbynck H, Coeck C, Galdermans D, et al. Dyspnea, fever, and eosinophilia. Chest 1993; 104:585.</a></li><li><a class="nounderline abstract_t">Balbi B, Fabiano F. A young man with fever, dyspnoea and nonproductive cough. Eur Respir J 1996; 9:619.</a></li><li class="breakAll">Cordier J-F, Cottin V. Eosinophilic pneumonias. In: Interstitial Lung Disease, 5th, Schwarz MI, King TE Jr (Eds), People's Medical Publishing House-USA, Shelton, CT 2011. p.833.</li><li><a class="nounderline abstract_t">Philit F, Etienne-Mastroïanni B, Parrot A, et al. Idiopathic acute eosinophilic pneumonia: a study of 22 patients. Am J Respir Crit Care Med 2002; 166:1235.</a></li><li><a class="nounderline abstract_t">Pope-Harman AL, Davis WB, Allen ED, et al. Acute eosinophilic pneumonia. A summary of 15 cases and review of the literature. Medicine (Baltimore) 1996; 75:334.</a></li><li><a class="nounderline abstract_t">Rom WN, Weiden M, Garcia R, et al. Acute eosinophilic pneumonia in a New York City firefighter exposed to World Trade Center dust. Am J Respir Crit Care Med 2002; 166:797.</a></li><li><a class="nounderline abstract_t">Hirai K, Yamazaki Y, Okada K, et al. Acute eosinophilic pneumonia associated with smoke from fireworks. Intern Med 2000; 39:401.</a></li><li><a class="nounderline abstract_t">Miki K, Miki M, Nakamura Y, et al. Early-phase neutrophilia in cigarette smoke-induced acute eosinophilic pneumonia. Intern Med 2003; 42:839.</a></li><li><a class="nounderline abstract_t">Watanabe K, Fujimura M, Kasahara K, et al. Acute eosinophilic pneumonia following cigarette smoking: a case report including cigarette-smoking challenge test. Intern Med 2002; 41:1016.</a></li><li><a class="nounderline abstract_t">Shiota Y, Kawai T, Matsumoto H, et al. Acute eosinophilic pneumonia following cigarette smoking. Intern Med 2000; 39:830.</a></li><li><a class="nounderline abstract_t">Shorr AF, Scoville SL, Cersovsky SB, et al. Acute eosinophilic pneumonia among US Military personnel deployed in or near Iraq. JAMA 2004; 292:2997.</a></li><li><a class="nounderline abstract_t">Al-Saieg N, Moammar O, Kartan R. Flavored cigar smoking induces acute eosinophilic pneumonia. Chest 2007; 131:1234.</a></li><li><a class="nounderline abstract_t">Grossi E, Poletti G, Poletti V. Acute eosinophilic pneumonia with respiratory failure: a case likely triggered by cigarette smoking. Monaldi Arch Chest Dis 2004; 61:58.</a></li><li><a class="nounderline abstract_t">Uchiyama H, Suda T, Nakamura Y, et al. Alterations in smoking habits are associated with acute eosinophilic pneumonia. Chest 2008; 133:1174.</a></li><li><a class="nounderline abstract_t">Rhee CK, Min KH, Yim NY, et al. Clinical characteristics and corticosteroid treatment of acute eosinophilic pneumonia. Eur Respir J 2013; 41:402.</a></li><li><a class="nounderline abstract_t">Shintani H, Fujimura M, Yasui M, et al. Acute eosinophilic pneumonia caused by cigarette smoking. Intern Med 2000; 39:66.</a></li><li><a class="nounderline abstract_t">Natarajan A, Shah P, Mirrakhimov AE, Hussain N. Eosinophilic pneumonia associated with concomitant cigarette and marijuana smoking. BMJ Case Rep 2013; 2013.</a></li><li><a class="nounderline abstract_t">Ogura N, Kono Y, To M, et al. Menthol-Flavored Cigarettes: Potentially a Strong Trigger of Acute Eosinophilic Pneumonia. Am J Med 2017; 130:e63.</a></li><li><a class="nounderline abstract_t">Yoon CG, Kim SJ, Kim K, et al. Clinical Characteristics and Factors Influencing the Occurrence of Acute Eosinophilic Pneumonia in Korean Military Personnel. J Korean Med Sci 2016; 31:247.</a></li><li><a class="nounderline abstract_t">De Giacomi F, Decker PA, Vassallo R, Ryu JH. Acute Eosinophilic Pneumonia: Correlation of Clinical Characteristics With Underlying Cause. Chest 2017; 152:379.</a></li><li><a class="nounderline abstract_t">Kitahara Y, Matsumoto K, Taooka Y, et al. Cigarette smoking-induced acute eosinophilic pneumonia showing tolerance in broncho-alveolar lavage findings. Intern Med 2003; 42:1016.</a></li><li><a class="nounderline abstract_t">Chung MK, Lee SJ, Kim MY, et al. Acute eosinophilic pneumonia following secondhand cigarette smoke exposure. Tuberc Respir Dis (Seoul) 2014; 76:188.</a></li><li><a class="nounderline abstract_t">Retzky SS. FDA Encourages Reporting of Tobacco Product Adverse Experiences. Chest 2016; 150:1169.</a></li><li><a class="nounderline abstract_t">Chabot C, Gouat F. Rare finding of acute eosinophilic pneumonia associated with heavy cannabis use: A case-report. Radiol Case Rep 2022; 17:3040.</a></li><li><a class="nounderline abstract_t">Thota D, Latham E. Case report of electronic cigarettes possibly associated with eosinophilic pneumonitis in a previously healthy active-duty sailor. J Emerg Med 2014; 47:15.</a></li><li><a class="nounderline abstract_t">Kamada T, Yamashita Y, Tomioka H. Acute eosinophilic pneumonia following heat-not-burn cigarette smoking. Respirol Case Rep 2016; 4:e00190.</a></li><li><a class="nounderline abstract_t">Arter ZL, Wiggins A, Hudspath C, et al. Acute eosinophilic pneumonia following electronic cigarette use. Respir Med Case Rep 2019; 27:100825.</a></li><li><a class="nounderline abstract_t">Wolf M, Richards J. Acute Eosinophilic Pneumonia Due to Vaping-Associated Lung Injury. J Crit Care Med (Targu Mures) 2020; 6:259.</a></li><li><a class="nounderline abstract_t">Tajiri T, Wada C, Ohkubo H, et al. Acute Eosinophilic Pneumonia Induced by Switching from Conventional Cigarette Smoking to Heated Tobacco Product Smoking. Intern Med 2020; 59:2911.</a></li><li><a class="nounderline abstract_t">Kang BH, Lee DH, Roh MS, et al. Acute Eosinophilic Pneumonia after Combined Use of Conventional and Heat-Not-Burn Cigarettes: A Case Report. Medicina (Kaunas) 2022; 58.</a></li><li><a class="nounderline abstract_t">Kwack TJ, Kim C, Hwang SH, et al. Electronic Cigarette or Vaping-Associated Lung Injury Manifested as Acute Eosinophilic Pneumonia: A Case Report. J Korean Soc Radiol 2023; 84:298.</a></li><li><a class="nounderline abstract_t">Takigawa Y, Sato K, Inoue A, et al. Acute eosinophilic pneumonia caused by nicotine-free vaping in an adolescent patient: A case report. Respirol Case Rep 2022; 10:e0961.</a></li><li><a class="nounderline abstract_t">Kodama T, Watanabe T, Mataki N, et al. Acute eosinophilic pneumonia following aromatherapy with essential oil. Respir Med Case Rep 2022; 37:101657.</a></li><li><a class="nounderline abstract_t">Al-Lehebi R, Alsardi M, Alshaya S. Aromatherapy may not be so relaxing after all: A case of acute eosinophilic pneumonia. Chest 2021; 160:A1198.</a></li><li><a class="nounderline abstract_t">Sine CR, Hiles PD, Scoville SL, et al. Acute eosinophilic pneumonia in the deployed military setting. Respir Med 2018; 137:123.</a></li><li><a class="nounderline abstract_t">Imokawa S, Sato A, Hayakawa H, et al. Possible involvement of an environmental agent in the development of acute eosinophilic pneumonia. Ann Allergy Asthma Immunol 1996; 76:419.</a></li><li><a class="nounderline abstract_t">Glazer CS, Cohen LB, Schwarz MI. Acute eosinophilic pneumonia in AIDS. Chest 2001; 120:1732.</a></li><li><a class="nounderline abstract_t">McCormick M, Nelson T. Cocaine-induced fatal acute eosinophilic pneumonia: a case report. WMJ 2007; 106:92.</a></li><li><a class="nounderline abstract_t">Brander PE, Tukiainen P. Acute eosinophilic pneumonia in a heroin smoker. Eur Respir J 1993; 6:750.</a></li><li><a class="nounderline abstract_t">Murao K, Saito A, Kuronuma K, et al. Acute eosinophilic pneumonia accompanied with COVID-19: a case report. Respirol Case Rep 2020; 8:e00683.</a></li><li><a class="nounderline abstract_t">Descalzo V, Salvador F, Sansano I, et al. Acute Eosinophilic Pneumonia Associated With SARS-CoV-2 Infection. Arch Bronconeumol 2021; 57 Suppl 2:50.</a></li><li><a class="nounderline abstract_t">Hu QD, Mao N, Huang XC, et al. Identification of Complex Pneumonia during the Outbreak of COVID-19: Bacterial Pneumonia Combined with Acute Eosinophilic Pneumonia in Patients with Maintenance Hemodialysis. Blood Purif 2021; 50:132.</a></li><li><a class="nounderline abstract_t">Tazelaar HD, Linz LJ, Colby TV, et al. Acute eosinophilic pneumonia: histopathologic findings in nine patients. Am J Respir Crit Care Med 1997; 155:296.</a></li><li><a class="nounderline abstract_t">Mochimaru H, Fukuda Y, Azuma A, et al. Reconsideration of discrepancies between clinical and histopathological features in acute eosinophilic pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 2015; 31:325.</a></li><li><a class="nounderline abstract_t">Janz DR, O'Neal HR Jr, Ely EW. Acute eosinophilic pneumonia: A case report and review of the literature. Crit Care Med 2009; 37:1470.</a></li><li><a class="nounderline abstract_t">Ricker DH, Taylor SR, Gartner JC Jr, Kurland G. Fatal pulmonary aspergillosis presenting as acute eosinophilic pneumonia in a previously healthy child. Chest 1991; 100:875.</a></li><li><a class="nounderline abstract_t">Buchheit J, Eid N, Rodgers G Jr, et al. Acute eosinophilic pneumonia with respiratory failure: a new syndrome? Am Rev Respir Dis 1992; 145:716.</a></li><li><a class="nounderline abstract_t">Umeki S, Soejima R. Acute and chronic eosinophilic pneumonia: clinical evaluation and the criteria. Intern Med 1992; 31:847.</a></li><li><a class="nounderline abstract_t">Umeki S. Reevaluation of eosinophilic pneumonia and its diagnostic criteria. Arch Intern Med 1992; 152:1913.</a></li><li><a class="nounderline abstract_t">Hayakawa H, Sato A, Toyoshima M, et al. A clinical study of idiopathic eosinophilic pneumonia. Chest 1994; 105:1462.</a></li><li><a class="nounderline abstract_t">Ogawa H, Fujimura M, Matsuda T, et al. Transient wheeze. Eosinophilic bronchobronchiolitis in acute eosinophilic pneumonia. Chest 1993; 104:493.</a></li><li><a class="nounderline abstract_t">Jantz MA, Sahn SA. Corticosteroids in acute respiratory failure. Am J Respir Crit Care Med 1999; 160:1079.</a></li><li><a class="nounderline abstract_t">Buddharaju VL, Saraceno JL, Rosen JM, et al. Acute eosinophilic pneumonia associated with shock. Crit Care Med 1999; 27:2014.</a></li><li><a class="nounderline abstract_t">Jhun BW, Kim SJ, Kim K, Lee JE. Clinical implications of initial peripheral eosinophilia in acute eosinophilic pneumonia. Respirology 2014; 19:1059.</a></li><li><a class="nounderline abstract_t">Andreu V, Bataller R, Caballería J, Rodés J. Acute eosinophilic pneumonia associated with ranitidine. J Clin Gastroenterol 1996; 23:160.</a></li><li><a class="nounderline abstract_t">Fleisch MC, Blauer F, Gubler JG, et al. Eosinophilic pneumonia and respiratory failure associated with venlafaxine treatment. Eur Respir J 2000; 15:205.</a></li><li class="breakAll">Camus, P. The drug-induced respiratory disease website. www.pneumotox.com (Accessed on December 02, 2014).</li><li><a class="nounderline abstract_t">Yakabe T, Kitahara K, Komiya K, et al. Severe eosinophilic pneumonia presenting during gemcitabine adjuvant chemotherapy. World J Surg Oncol 2013; 11:167.</a></li><li><a class="nounderline abstract_t">Hirai J, Hagihara M, Haranaga S, et al. Eosinophilic pneumonia caused by daptomycin: Six cases from two institutions and a review of the literature. J Infect Chemother 2017; 23:245.</a></li><li><a class="nounderline abstract_t">Uppal P, LaPlante KL, Gaitanis MM, et al. Daptomycin-induced eosinophilic pneumonia - a systematic review. Antimicrob Resist Infect Control 2016; 5:55.</a></li><li><a class="nounderline abstract_t">Foong KS, Lee A, Pekez M, Bin W. Imipenem/cilastatin-induced acute eosinophilic pneumonia. BMJ Case Rep 2016; 2016.</a></li><li><a class="nounderline abstract_t">Franco AI, Escobar L, García XA, et al. Mesalazine-induced eosinophilic pneumonia in a patient with ulcerative colitis disease: a case report and literature review. Int J Colorectal Dis 2016; 31:927.</a></li><li><a class="nounderline abstract_t">Yoshimi M, Nannya Y, Watanabe T, et al. Acute eosinophilic pneumonia is a non-infectious lung complication after allogeneic hematopoietic stem cell transplantation. Int J Hematol 2009; 89:244.</a></li><li><a class="nounderline abstract_t">Tsigkaropoulou E, Hatzilia D, Rizos E, et al. Venlafaxine-induced acute eosinophilic pneumonia. Gen Hosp Psychiatry 2011; 33:411.e7.</a></li><li><a class="nounderline abstract_t">Inoue M, Horita N, Kimura N, et al. Three cases of mesalazine-induced pneumonitis with eosinophilia. Respir Investig 2014; 52:209.</a></li><li><a class="nounderline abstract_t">Amiconi S. How are Eosinophils Supplied from Bone Marrow to Eosinophil-Infiltrated Tissues, When Blood Eosinophilia is Not Observed? The Case of Acute Eosinophilic Pneumonia. N Am J Med Sci 2014; 6:349.</a></li><li><a class="nounderline abstract_t">Allen JN, Davis WB. Eosinophilic lung diseases. Am J Respir Crit Care Med 1994; 150:1423.</a></li><li><a class="nounderline abstract_t">Abe K, Yanagi S, Imadsu Y, et al. Acute eosinophilic pneumonia with fine nodular shadows. Intern Med 2003; 42:88.</a></li><li><a class="nounderline abstract_t">Daimon T, Johkoh T, Sumikawa H, et al. Acute eosinophilic pneumonia: Thin-section CT findings in 29 patients. Eur J Radiol 2008; 65:462.</a></li><li><a class="nounderline abstract_t">Cheon JE, Lee KS, Jung GS, et al. Acute eosinophilic pneumonia: radiographic and CT findings in six patients. AJR Am J Roentgenol 1996; 167:1195.</a></li><li><a class="nounderline abstract_t">Swartz J, Stoller JK. Acute eosinophilic pneumonia complicating Coccidioides immitis pneumonia: a case report and literature review. Respiration 2009; 77:102.</a></li><li><a class="nounderline abstract_t">Miyazaki E, Sugisaki K, Shigenaga T, et al. A case of acute eosinophilic pneumonia caused by inhalation of Trichosporon terrestre. Am J Respir Crit Care Med 1995; 151:541.</a></li><li><a class="nounderline abstract_t">Nesbit LA, Knox KS, Nguyen CT, et al. Immunological characterization of bronchoalveolar lavage fluid in patients with acute pulmonary coccidioidomycosis. J Infect Dis 2013; 208:857.</a></li><li><a class="nounderline abstract_t">Mouri M, Nambu Y, Horii H, et al. [Case report and review of literature on seasonal distribution and pathogenesis of acute eosinophilic pneumonia in Japan]. Nihon Kyobu Shikkan Gakkai Zasshi 1993; 31:1578.</a></li><li><a class="nounderline abstract_t">Imokawa S, Sato A, Taniguchi M, et al. [Two cases of acute eosinophilic pneumonia with precipitating antibody against Trichosporon cutaneum and Trichoderma viride]. Nihon Kyobu Shikkan Gakkai Zasshi 1993; 31:352.</a></li><li><a class="nounderline abstract_t">Suzuki T, Nagai K, Wakazono N, et al. Acute eosinophilic pneumonia caused by composter vapor inhalation: A case report. Respir Investig 2022; 60:857.</a></li><li><a class="nounderline abstract_t">Trawick D, Kotch A, Matthay R, Homer RJ. Eosinophilic pneumonia as a presentation of occult chronic granulomatous disease. Eur Respir J 1997; 10:2166.</a></li><li><a class="nounderline abstract_t">Allen J. Acute eosinophilic pneumonia. Semin Respir Crit Care Med 2006; 27:142.</a></li><li><a class="nounderline abstract_t">Jhun BW, Kim SJ, Kim K, Lee JE. Outcomes of rapid corticosteroid tapering in acute eosinophilic pneumonia patients with initial eosinophilia. Respirology 2015; 20:1241.</a></li></ol></div><div id="topicVersionRevision">Topic 4374 Version 30.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2912347" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Acute eosinophilic pneumonia: a hypersensitivity phenomenon?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2761601" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1842125" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : [Eosinophilic pneumonia causing severe respiratory insufficiency. Clinical case].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1421726" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Idiopathic acute eosinophilic pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8339651" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Dyspnea, fever, and eosinophilia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8730029" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : A young man with fever, dyspnoea and nonproductive cough.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8730029" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : A young man with fever, dyspnoea and nonproductive cough.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12403693" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Idiopathic acute eosinophilic pneumonia: a study of 22 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8982150" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Acute eosinophilic pneumonia. A summary of 15 cases and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12231487" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Acute eosinophilic pneumonia in a New York City firefighter exposed to World Trade Center dust.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10830182" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Acute eosinophilic pneumonia associated with smoke from fireworks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14518673" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Early-phase neutrophilia in cigarette smoke-induced acute eosinophilic pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12487181" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Acute eosinophilic pneumonia following cigarette smoking: a case report including cigarette-smoking challenge test.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11030209" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Acute eosinophilic pneumonia following cigarette smoking.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15613668" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Acute eosinophilic pneumonia among US Military personnel deployed in or near Iraq.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17426233" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Flavored cigar smoking induces acute eosinophilic pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15366338" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Acute eosinophilic pneumonia with respiratory failure: a case likely triggered by cigarette smoking.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18263675" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Alterations in smoking habits are associated with acute eosinophilic pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22599359" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Clinical characteristics and corticosteroid treatment of acute eosinophilic pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10674853" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Acute eosinophilic pneumonia caused by cigarette smoking.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23645642" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Eosinophilic pneumonia associated with concomitant cigarette and marijuana smoking.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28117040" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Menthol-Flavored Cigarettes: Potentially a Strong Trigger of Acute Eosinophilic Pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26839479" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Clinical Characteristics and Factors Influencing the Occurrence of Acute Eosinophilic Pneumonia in Korean Military Personnel.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28286263" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Acute Eosinophilic Pneumonia: Correlation of Clinical Characteristics With Underlying Cause.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14606718" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Cigarette smoking-induced acute eosinophilic pneumonia showing tolerance in broncho-alveolar lavage findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24851134" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Acute eosinophilic pneumonia following secondhand cigarette smoke exposure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27938736" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : FDA Encourages Reporting of Tobacco Product Adverse Experiences.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35769119" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Rare finding of acute eosinophilic pneumonia associated with heavy cannabis use: A case-report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24462024" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Case report of electronic cigarettes possibly associated with eosinophilic pneumonitis in a previously healthy active-duty sailor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28031826" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Acute eosinophilic pneumonia following heat-not-burn cigarette smoking.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30963023" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Acute eosinophilic pneumonia following electronic cigarette use.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33200099" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Acute Eosinophilic Pneumonia Due to Vaping-Associated Lung Injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32713912" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Acute Eosinophilic Pneumonia Induced by Switching from Conventional Cigarette Smoking to Heated Tobacco Product Smoking.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36363483" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Acute Eosinophilic Pneumonia after Combined Use of Conventional and Heat-Not-Burn Cigarettes: A Case Report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36818711" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Electronic Cigarette or Vaping-Associated Lung Injury Manifested as Acute Eosinophilic Pneumonia: A Case Report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35592268" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Acute eosinophilic pneumonia caused by nicotine-free vaping in an adolescent patient: A case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35573977" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Acute eosinophilic pneumonia following aromatherapy with essential oil.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Aromatherapy may not be so relaxing after all: A case of acute eosinophilic pneumonia</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29605194" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Acute eosinophilic pneumonia in the deployed military setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8630714" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Possible involvement of an environmental agent in the development of acute eosinophilic pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11713161" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Acute eosinophilic pneumonia in AIDS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17479827" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Cocaine-induced fatal acute eosinophilic pneumonia: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8519388" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Acute eosinophilic pneumonia in a heroin smoker.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33235798" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Acute eosinophilic pneumonia accompanied with COVID-19: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33446345" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Acute Eosinophilic Pneumonia Associated With SARS-CoV-2 Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32721968" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Identification of Complex Pneumonia during the Outbreak of COVID-19: Bacterial Pneumonia Combined with Acute Eosinophilic Pneumonia in Patients with Maintenance Hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9001328" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Acute eosinophilic pneumonia: histopathologic findings in nine patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25591144" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Reconsideration of discrepancies between clinical and histopathological features in acute eosinophilic pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19242348" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Acute eosinophilic pneumonia: A case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1889295" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Fatal pulmonary aspergillosis presenting as acute eosinophilic pneumonia in a previously healthy child.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1546855" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Acute eosinophilic pneumonia with respiratory failure: a new syndrome?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1450493" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Acute and chronic eosinophilic pneumonia: clinical evaluation and the criteria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1520060" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Reevaluation of eosinophilic pneumonia and its diagnostic criteria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8181338" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : A clinical study of idiopathic eosinophilic pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8339639" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Transient wheeze. Eosinophilic bronchobronchiolitis in acute eosinophilic pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10508792" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Corticosteroids in acute respiratory failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10507633" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Acute eosinophilic pneumonia associated with shock.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24985714" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Clinical implications of initial peripheral eosinophilia in acute eosinophilic pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8877651" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Acute eosinophilic pneumonia associated with ranitidine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10678647" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Eosinophilic pneumonia and respiratory failure associated with venlafaxine treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10678647" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Eosinophilic pneumonia and respiratory failure associated with venlafaxine treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23883337" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Severe eosinophilic pneumonia presenting during gemcitabine adjuvant chemotherapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28003110" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Eosinophilic pneumonia caused by daptomycin: Six cases from two institutions and a review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27999664" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Daptomycin-induced eosinophilic pneumonia - a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26944380" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Imipenem/cilastatin-induced acute eosinophilic pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26189026" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Mesalazine-induced eosinophilic pneumonia in a patient with ulcerative colitis disease: a case report and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19132457" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Acute eosinophilic pneumonia is a non-infectious lung complication after allogeneic hematopoietic stem cell transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21762842" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Venlafaxine-induced acute eosinophilic pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24853024" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Three cases of mesalazine-induced pneumonitis with eosinophilia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25077086" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : How are Eosinophils Supplied from Bone Marrow to Eosinophil-Infiltrated Tissues, When Blood Eosinophilia is Not Observed? The Case of Acute Eosinophilic Pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7952571" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Eosinophilic lung diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12583626" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Acute eosinophilic pneumonia with fine nodular shadows.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17537607" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Acute eosinophilic pneumonia: Thin-section CT findings in 29 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8911179" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Acute eosinophilic pneumonia: radiographic and CT findings in six patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17940333" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Acute eosinophilic pneumonia complicating Coccidioides immitis pneumonia: a case report and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7842218" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : A case of acute eosinophilic pneumonia caused by inhalation of Trichosporon terrestre.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23737603" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Immunological characterization of bronchoalveolar lavage fluid in patients with acute pulmonary coccidioidomycosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8121096" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : [Case report and review of literature on seasonal distribution and pathogenesis of acute eosinophilic pneumonia in Japan].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8315904" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : [Two cases of acute eosinophilic pneumonia with precipitating antibody against Trichosporon cutaneum and Trichoderma viride].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36153289" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Acute eosinophilic pneumonia caused by composter vapor inhalation: A case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9311521" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Eosinophilic pneumonia as a presentation of occult chronic granulomatous disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16612765" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Acute eosinophilic pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26333129" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Outcomes of rapid corticosteroid tapering in acute eosinophilic pneumonia patients with initial eosinophilia.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
